{
    "clinical_study": {
        "@rank": "77076", 
        "biospec_descr": {
            "textblock": "Blood, Plasma"
        }, 
        "brief_summary": {
            "textblock": "The current state of knowledge on the concentration of drugs and their metabolites in the\n      individual human body is not satisfying concerning the question about behavior of drugs in\n      the human body, taking into account individual patient factors such as age, weight and organ\n      dysfunctions.\n\n      This projects deals with the question of drug levels in the blood of hospitalized patients.\n\n      The aim of this study is to extend the knowledge about the behavior of drugs in the human\n      body significantly, for the safety and benefit of future patients. This also includes to\n      establish a relationship between drug levels in patients and the desired and undesired\n      effects of a drug.\n\n      As a result, the future perspective is to find the optimal dose for the individual patient\n      by measuring the blood concentration of a drug."
        }, 
        "brief_title": "Determination of Drugs and Their Metabolites in Hospitalized Patients", 
        "condition": "Neoplasms", 
        "condition_browse": {
            "mesh_term": "Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "The primary goal of the study is to gain an overview of the plasma concentrations of\n      relevant drugs which occur in different patient populations and to what extent they are\n      consistent with those concentrations described in the literature.\n\n      If the expectation is confirmed, that a significant heterogeneity in the plasma\n      concentrations of these patients exists, the investigators will try to find influencing\n      factors for this circumstance on the basis of routine clinical parameters (height, weight,\n      renal function, concomitant medications, etc.).\n\n      Ultimately, this project will identify substances with a high interindividual variability in\n      plasma levels, where drug monitoring might be suggested."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  legal capacity\n\n        Exclusion Criteria:\n\n          -  severe anemia"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Hospitalized patients"
            }
        }, 
        "enrollment": {
            "#text": "1000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 1, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01702545", 
            "org_study_id": "PEAK-001"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "November 21, 2013", 
        "location": {
            "contact": {
                "email": "martin.wilhelm@klinikum-nuernberg.de", 
                "last_name": "Martin Wilhelm, Prof. Dr.", 
                "phone": "00499113983050"
            }, 
            "facility": {
                "address": {
                    "city": "N\u00fcrnberg", 
                    "country": "Germany", 
                    "state": "Bavaria", 
                    "zip": "90419"
                }, 
                "name": "Dept. of Internal Medicine V, Klinikum N\u00fcrnberg Nord"
            }, 
            "investigator": {
                "last_name": "Martin Wilhelm, Prof. Dr.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_groups": "1", 
        "overall_contact": {
            "email": "martin.wilhelm@klinikum-nuernberg.de", 
            "last_name": "Martin Wilhelm, Prof. Dr.", 
            "phone": "00499113983050"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: University Hospital Erlangen"
        }, 
        "phase": "N/A", 
        "primary_outcome": {
            "measure": "Plasma concentrations [ng/mL] of various drugs at different timepoints"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01702545"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Klinikum N\u00fcrnberg", 
            "investigator_full_name": "Mr. Prof. Dr. Wilhelm", 
            "investigator_title": "Prof. Dr. med. Martin Wilhelm", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Klinikum N\u00fcrnberg", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Klinikum N\u00fcrnberg", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "November 2013"
    }
}